Catecholamines are the only hormones with pronounced lipolytic action in man. A number of in vivo and in vitro studies suggest that there is lipolytic resistance to catecholamines in subcutaneous adipose tissue, which is the major fat depot in obese subjects. This is due to multiple alterations in catecholamine signal transduction, involving decreased expression and function of b b 2 -adrenoceptors, increased function of a a 2 -adrenoceptors and decreased ability of cyclic monophosphate (AMP) to stimulate hormone sensitive lipase. A sedentary life-style, which usually characterizes obesity, may contribute to the catecholamine resistance. However, hereditaryagenetic factors may also be involved. Recently, decreased expression and function of hormone sensitive lipase has been found in subcutaneous adipocytes of non-obese subjects with heredity for obesity. In addition, polymorphisms in the genes for b b 2 -adrenoceptors, b b 3 -adrenoceptors and hormone sensitive lipase, associate with obesity. On the other hand, catecholamine-induced lipolysis in visceral adipose tissue is increased in obesity due to increased function of b b 3 -adrenoceptors (major ®nding), decreased function of a a 2 -adrenoceptors and increased ability of cyclic AMP to stimulate lipolysis. When the ®ndings in different adipose regions are considered together, it appears that there is a redistribution of lipolysis and thereby fatty acid mobilization in obesity, favouring the visceral fat depot. This leads to an increase in the circulating fatty acid levels in the portal vein, which connects visceral fat with the liver. As a consequence, the liver function may be altered leading to hyperinsulinemia, hyperglycemia and dyslipidemia, which usually accompany the obese state.
Introduction
Adipose tissue plays a central role in energy homeostasis through its ability to store and release large amounts of energy rich fatty acids. Alterations in these processes are important for the development of obesity and many obesity complications, as reviewed in detail recently. 1 Fatty acids are mobilized from the fat depots through hydrolysis (lipolysis) of triglycerides in fat cells. In humans, only catecholamines have a pronounced acute stimulatory effect on lipolysis. 2 Recent data suggest that alterations in this hormonal regulation may be of importance for the development of obesity and several of its metabolic complications. This review deals with recent ®ndings, as regards catecholamines induced lipolysis in relationship to obesity in man. Lipolysis has been discussed in detail as regards earlier ®ndings in man. 2 In the interest of space, review articles rather than original publications will be cited as often as possible
Mechanisms of catecholamine action
The mechanisms by which catecholamines regulate lipolysis in human fat cells are known in some detail. 2 At the cellular level, the hormones ®rst bind to four different adrenoceptor subtypes on the cell surface. Beta 1 , beta 2 and beta 3 (b 1 , b 2 and b 3 )-receptors are coupled to stimulatory GTP sensitive proteins and activate the membrane bound enzyme adenylyl cyclase which enhances the breakdown of intracellular adenosine triphosphate (ATP) to cyclic AMP. The latter nucleotide activates protein kinase A, which in turn phosphorylates hormone sensitive lipase (HSL). Thereby HSL becomes activated and catalyzes the breakdown of triglycerides (lipolysis), whereafter fatty acids are liberated and can leave the fat cells to be transported by the blood stream for utilization in other organs (mainly the liver and the muscle). a 2 -Aadrenoceptors have opposite effects on lipolysis. They couple to inhibitory GTP sensitive proteins so that adenylyl cyclase, cyclic AMP formation, protein kinase A activation, HSL phosphorylation and lipolysis are inhibited.
It is unknown so far why human fat cells need three stimulatory and one inhibitory receptor for such a relatively simple process as catecholamine-regulation of lipolysis. In most other species only one or two A number of physiological factors modulate catecholamine action on lipolysis in fat cells (Table 1) . Several other hormones have permissive (usually stimulatory) effects. Aging, fasting, trauma and exercise, modulate catecholamine-induced lipolysis, usually exerting a stimulatory effect, except for aging which has an inhibitory effect.
As discussed in detail later in this review, the regional variations in catecholamine-induced lipolysis are of great potential importance for obesity. Using different approaches, such as microdialysis and isotopic infusion in combination with selective blood vessel catheterization, it is ®rmly established that the in vivo lipolytic response to catecholamines differs between central and peripheral subcutaneous adipose tissue as reviewed recently. 3 It has been suggested that regional variations in subcutaneous lipolysis could be of importance for body fat distribution (see Ref. 4 for a detailed discussion). Catecholamine-induced lipolysis is more marked in abdominal, as compared to gluteofemoral, subcutaneous fat and this difference is more marked in women than in men and also maintained in obesity. Thus, catecholamines could play a role for the development of certain obese phenotypes such as upper-body obesity (usually occurring in men) and peripheral obesity (usually occurring in women).
Of greater pathophysiological importance than variation in lipolysis between subcutaneous fat depots is probably the lipolytic differences between subcutaneous and visceral adipose tissue (see Ref. 5 for detailed information). Only visceral adipose tissue is in direct contact with the liver, since it is drained by the portal vein. A high fatty acid concentration in the liver, for example induced by excess`portal' delivery, has a number of undesirable effects on the organ. Gluconeogenesis and triglyceride production are stimulated. Insulin breakdown is inhibited. Thus, high portal' fatty acids may induce hyperglycemia, dyslipidemia and hyperinsulinemia, which all are common abnormalities in obese subjects. It should be stressed that the evidence for a difference in lipolysis between visceral and subcutaneous adipose tissue is based on in vitro studies. For ethical reasons it is not possible to directly study the visceral lipolysis rate with current techniques. The rate of lipolysis is much higher in visceral as compared to subcutaneous fat cells in vitro. This is due to regional variations in the action of a number of hormones. For catecholamines, the lipolytic action of the b-adrenoreceptor subtypes are more pronounced and the antilipolytic action of a 2 -receptors less pronounced in visceral as compared to subcutaneous adipocytes. Recent studies suggest that, in men, these regional variations in catecholamine action are more pronounced in obese as compared to non-obese subjects. 6 Regional variations in catecholamine-induced lipolysis may have physiological as well as pathophysiological (see below) implications. Gluteofemoral lipolysis is enhanced in lactating women and fatty acids from this depot could serve as energy substrate during lactation. Visceral fatty acid mobilization could be of importance in situations when there is rapid need for excess endogenous energy supply such as during physical work.
Catecholamine action in obesity
As reviewed earlier, 2,3 a number of in vivo studies have shown that the lipolytic action of catecholamines is blunted in vivo in obese subjects. This defect might be an early event in obesity, since it is observed in obese adolescents. 7 On the basis of in vitro studies on subcutaneous fat cells (see reference 2 for details) it can be concluded that the catecholamine resistance is caused by multiple defects in signal transduction (Table 2) . Decreased expression and function of b 2 -adrenoceptors, increased antilipolytic action of a 2 -adrenoceptors and impaired ability of cyclic AMP to activate lipolysis are found in subcutaneous fat cells of obese subjects.
The ®ndings of visceral adipocytes in obesity (Table 2) are, on the other hand, much different from those with subcutaneous fat cells. In the visceral fat depot catecholamine-induced lipolysis is increased (see reference 2 for details). The mechanisms seem to be enhanced lipolytic function of b 3 -adrenoceptors, decreased antilipolytic function of a 2 -adrenoceptors and increased ability of cyclic AMP to activate lipolysis. These ®ndings at large opposite to those found in subcutaneous fat cells of obese subjects. Recent studies suggest that gender is also of importance for catecholamine action on visceral fat cell lipolysis in obesity. 8 The rate of lipolysis is much higher in visceral fat cells of obese men in comparison with obese women; the mechanism for the observed differences are the same as those described above.
When available data are considered together, the following speculation on catecholamine-induced lipolysis is presented (Figure 1 ). The action is increased in visceral fat cells, but decreased in subcutaneous fat cells, due to multiple alterations in the catecholamine signal transduction pathway for lipolysis in these two cell types. As a consequence, there is a re-distribution of fatty acid mobilization from adipose tissue, favouring the visceral over the subcutaneous depot. This could be a mechanism behind abdominal obesity since the subcutaneous abdominal fat depot is the largest adipose region in this obese phenotype. It could also be a mechanism for many of the metabolic complications which are caused by abdominal obesity. Increased visceral mobilization of fatty acids resulting in elevated`portal' fatty acids and impaired liver function may, at least in part, be responsible for the atherogenic metabolic pro®le in abdominal obesity. It has recently been suggested that an increase in the size of the visceral fat depot is the precursor for elevated portal' fatty acids. 9 However, the data reviewed in the present article also support the view that changes in the rate of lipolysis per se (independent of the size of the visceral fat depot) contribute to excess mobilization of portal fatty acids in upper-body (abdominal) obesity. However, it should be noted that the theory on regional fat lipolysis is based almost completely on in vitro studies.
Primary and secondary events
What comes ®rst, obesity or defects in the action of catecholamines on lipolysis? Although this question cannot be ®rmly answered yet, it is possible that both primary and secondary factors are of importance ( Table 3) .
A hen-and egg question regarding obesity can sometimes be answered by investigations performed before and after weight reduction. The information of lipolysis regulation before and after weight reduction is limited as regards earlier studies (see Ref. 2) . Recently it was demonstrated that a 20% weight reduction partly normalized lipolysis regulation in subcutaneous fat cells of obese women. 10 Another recent study on formerly obese women showed that in vivo lipolysis in subcutaneous adipose tissue during exercise (a condition when lipolysis is accelerated mainly due to increase of circulating catecholamines) was not different from that in never-obese control subjects. 11 However, no information was available in this study on lipolysis before the women lost weight. The question as to whether or not lipolysis abnormalities persist after weight reduction can best be explained by a comparison of the same subjects in the obese and post-obese states.
Most obese subjects have a sedentary life-style and excess caloric intake. Earlier studies (reviewed in reference 2) indicate that exercise and endurance training improves the lipolytic action of catecholamines in subcutaneous fat, whereas over-feeding has no or small effects. Recent data further support the notion that a low level of physical activity, not a high caloric intake, play a role for resistance to the lipolytic action of catecholamine in obesity. Overfeeding for 100 d resulting in 6 kg weight gain did not alter catecholamine-stimulated lipolysis in subcutaneous fat cells of non-obese subjects. 12 Catecholamineinduced lipolysis was more pronounced in subcutaneous adipocytes from endurance-trained women than from sedentary women, owing to increased b-adrenoceptor function and decreased a 2 -adrenoceptor function. 13 However, it should be kept in mind that the interactions between lipolysis and exercise have mainly been investigated in vitro on fat cells. Recent studies suggest that exercise does not in¯uence catecholamine-induced lipolysis in vitro. 2. Improved lipolysis following weight reduction.
Lipolysis in obesity P Arner
There is both direct and indirect evidence that catecholamine-induced lipolysis is under hereditary in¯uence. Earlier studies on subcutaneous fat cells (reviewed in Ref. 2 and Ref. 12) show, ®rst, a resemblance of lipolysis stimulation in homozygous twins and, second, a bimodal distribution of b 2 -adrenoceptor sensitivity and liplolytic function in the nonobese population. These data suggest that variations in catecholamine action (in particular via b 2 -receptor) between individuals are genetically determined. Further support for this notion is the recent ®nding that a common structural variation in the b 2 -adrenoceptor protein is associated with lipolytic variability. 15 Recent data also argue that hereditary defects in catecholamine-induced lipolysis are linked to obesity. Subcutaneous fat cells of non-obese subjects, who have heredity of obesity among ®rst degree relatives, display resistance to catecholamine-induced lipolysis owing to a defect in hormone sensitive lipase function. 16 Polymorphism in the hormone sensitive lipase gene is more common among obese than among nonobese subjects. 17 Polymorphisms in the b 2 -adrenoceptor gene have a strong association to obesity in women. 15 Finally, a coding polymorphism in the b 3 -adrenoceptor gene, Trp64Arg, was demonstrated some years ago and has been intensity investigated (see Ref. 18 for details) . In some studies, the polymorphism is associated with obesity and altered b 3 -receptor function whereas other investigations have failed to demonstrate any phenotypic effects of the polymorphism.
Conclusion
Recent data may indicate that both environmental and genetic factors modify the action of catecholamines on lipolysis in fat cells with consequences for the development of obesity. A sedentary life-style may promote catecholamine-resistance. Structural variations in the genes for b 2 -adrenoceptors, b 3 -adrenoceptors an hormone-sensitive lipase or in other genes regulating the expression andaor function of the previously mentioned genes could impair lipolysis and promote the development of obesity. Clearly much more information is needed about primary and secondary events in lipolysis regulation in obese subjects.
